PROCEPT BioRobotics Corporation IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| PROCEPT BioRobotics Corporation | PRCT - NASDAQ |
$22.00-$24.00 | $25.00 | $35.00 | 6.6 million | 9/15/2021 |
| BofA Securities, Goldman Sachs | ||||||
Co-Manager(s): Cowen, Guggenheim Securities, SVB Leerink
| ||||||
Filing(s): Filed 2021-08-18 Terms Added 2021-09-08 | ||||||
PROCEPT BioRobotics Corporation Quote & Chart - Click for current quote - PRCT
IPO Boutique aggregates information on public companies and private companies, such as "PRCT" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About PROCEPT BioRobotics Corporation (adapted from PROCEPT BioRobotics Corporation prospectus):
They are a commercial-stage surgical robotics company focused on advancing patient care by developing transformative solutions in urology.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a commercial-stage surgical robotics company focused on advancing patient care by developing transformative solutions in urology.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "PRCT" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.